EP0346445A4 - Dextrorphan potentiator for anticonvulsant composition and method. - Google Patents

Dextrorphan potentiator for anticonvulsant composition and method.

Info

Publication number
EP0346445A4
EP0346445A4 EP19890901396 EP89901396A EP0346445A4 EP 0346445 A4 EP0346445 A4 EP 0346445A4 EP 19890901396 EP19890901396 EP 19890901396 EP 89901396 A EP89901396 A EP 89901396A EP 0346445 A4 EP0346445 A4 EP 0346445A4
Authority
EP
European Patent Office
Prior art keywords
dextrorphan
potentiator
anticonvulsant composition
anticonvulsant
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19890901396
Other languages
German (de)
French (fr)
Other versions
EP0346445A1 (en
Inventor
John W Ael Ferkany
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0346445A1 publication Critical patent/EP0346445A1/en
Publication of EP0346445A4 publication Critical patent/EP0346445A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
EP19890901396 1987-12-22 1988-12-19 Dextrorphan potentiator for anticonvulsant composition and method. Withdrawn EP0346445A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13656487A 1987-12-22 1987-12-22
US136564 1987-12-22

Publications (2)

Publication Number Publication Date
EP0346445A1 EP0346445A1 (en) 1989-12-20
EP0346445A4 true EP0346445A4 (en) 1990-03-28

Family

ID=22473385

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19890901396 Withdrawn EP0346445A4 (en) 1987-12-22 1988-12-19 Dextrorphan potentiator for anticonvulsant composition and method.

Country Status (4)

Country Link
EP (1) EP0346445A4 (en)
JP (1) JPH02502546A (en)
AU (1) AU2929489A (en)
WO (1) WO1989005642A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686086A (en) * 1992-07-13 1997-11-11 Shiseido Co., Ltd. External skin treatment composition
US5798109A (en) * 1992-07-13 1998-08-25 Shiseido Company, Ltd. External skin treatment composition
US5962000A (en) * 1992-07-13 1999-10-05 Shiseido Company, Ltd. External skin treatment composition
ES2241055T3 (en) * 1996-08-23 2005-10-16 Endo Pharmaceuticals Inc COMPOSITION CONTAINING AN ANTIBONVULSIONANT TO TREAT NEUROPATHIC PAIN.
WO1999008670A1 (en) 1997-08-20 1999-02-25 Guglietta, Antonio Gaba analogs to prevent and treat gastrointestinal damage
DK1011658T3 (en) 1997-09-08 2006-04-03 Warner Lambert Co Analgesic compositions comprising antiepileptic compounds and methods for using the same
AU2002301362B8 (en) * 1997-09-08 2006-05-04 Warner-Lambert Company Analgesic compositions comprising anti-epileptic compounds and methods of using same
EP1471909A4 (en) * 2002-01-16 2007-07-25 Endo Pharmaceuticals Inc Pharmaceutical composition and method for treating disorders of the central nervous system
GB0307860D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Organic compounds
HUP0300929A3 (en) * 2003-04-09 2005-06-28 Richter Gedeon Vegyeszet Analgetic and/or muscle relaxant pharmaceutical composition
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
WO2014173900A1 (en) * 2013-04-22 2014-10-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Method and pharmaceutical composition for use in the treatment of epileptic seizures

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4380548A (en) * 1981-08-27 1983-04-19 Warner-Lambert Company N-(2,6-Dimethylphenyl)-4,5-dihydro-4,4-dialkyl-2-methylthio-1H-imidazole-1-carboxamides, anticonvulsive composition and method
US4694010A (en) * 1985-08-16 1987-09-15 New York University Anticonvulsant compositions and method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No relevant documents have been disclosed. *
See also references of WO8905642A1 *

Also Published As

Publication number Publication date
AU2929489A (en) 1989-07-19
WO1989005642A1 (en) 1989-06-29
JPH02502546A (en) 1990-08-16
EP0346445A1 (en) 1989-12-20

Similar Documents

Publication Publication Date Title
GB8814705D0 (en) Method
HK3095A (en) Emulsification method
EP0233932A4 (en) Anticonvulsant compositions and method.
EP0346445A4 (en) Dextrorphan potentiator for anticonvulsant composition and method.
GB8913090D0 (en) Method
GB2208669B (en) Grouting method
GB8822145D0 (en) Method
EP0578138A3 (en) Gene-detecting method.
EP0278681A3 (en) An antihepatopathic composition
EP0371085A4 (en) Dextromethorphan potentiator for anticonvulsant composition and method
AU2463988A (en) An improved method and composition
EP0320789A3 (en) Connecting method
GB8829942D0 (en) Method
GB8722188D0 (en) Dispensing method
GB9111738D0 (en) Method
EP0327273A3 (en) Dyeimage forming method
PH25234A (en) Expression method
GB8701920D0 (en) Marking method
IE872149L (en) Hair-cleaning method and composition.
GB8812516D0 (en) Improved construction method
GB9200682D0 (en) Noncorruptible read-writer method
GB2211433B (en) Mixing method
GB8712413D0 (en) Printing method
GB8709738D0 (en) Method &amp; still
GB8708440D0 (en) Pharmaceutical method &amp; composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19900328

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19891230